Filing Flows › Stryker (SYK) › MedSurg and Neurotechnology: revenue
Stryker (SYK) MedSurg and Neurotechnology: revenue by quarter
Stryker's MedSurg and Neurotechnology: revenue was $3.7B in Q3 2026 (third quarter 2026), +1% from Q2 2026. Over the last 6 quarters it ranged from $3.2B (Q1 2026) to $3.8B (Q3 2025).
| Quarter | MedSurg and Neurotechnology: revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.7B | +1% | -4% |
| Q2 2026 | $3.6B | +13% | -4% |
| Q1 2026 | $3.2B | -16% | -9% |
| Q3 2025 | $3.8B | +0.8% | — |
| Q2 2025 | $3.8B | +7% | — |
| Q1 2025 | $3.5B | — | — |
Q3 2026 at a glance
Stryker, Q3 2026: revenue $6.5B (+8% year over year), operating margin 15.9%, net earnings $753M, operating cash flow $1.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Stryker's MedSurg and Neurotechnology: revenue?
Stryker's MedSurg and Neurotechnology: revenue was $3.7B in Q3 2026 (third quarter 2026), +1% from Q2 2026.
How has Stryker's MedSurg and Neurotechnology: revenue changed?
Over the last 6 quarters it ranged from $3.2B (Q1 2026) to $3.8B (Q3 2025).